447 related articles for article (PubMed ID: 16321766)
1. Muir-Torre syndrome.
Ponti G; Ponz de Leon M
Lancet Oncol; 2005 Dec; 6(12):980-7. PubMed ID: 16321766
[TBL] [Abstract][Full Text] [Related]
2. [Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis].
Doré MX; Dieumegard B; Grandjouan S; Avril MF; Martinet C; Ducreux M; Lasser P; Bressac-de Paillerets B
Ann Dermatol Venereol; 1999; 126(8-9):582-6. PubMed ID: 10530344
[TBL] [Abstract][Full Text] [Related]
3. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
[TBL] [Abstract][Full Text] [Related]
4. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.
Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S
J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164
[TBL] [Abstract][Full Text] [Related]
5. Muir-Torre syndrome: clinical features and molecular genetic analysis.
Esche C; Kruse R; Lamberti C; Friedl W; Propping P; Lehmann P; Ruzicka T
Br J Dermatol; 1997 Jun; 136(6):913-7. PubMed ID: 9217825
[TBL] [Abstract][Full Text] [Related]
6. Muir-Torre syndrome.
Cohen PR; Kohn SR; Davis DA; Kurzrock R
Dermatol Clin; 1995 Jan; 13(1):79-89. PubMed ID: 7712655
[TBL] [Abstract][Full Text] [Related]
7. Muir-torre syndrome with intriguing squamous lesions: a case report and review of the literature.
Nishizawa A; Nakanishi Y; Sasajima Y; Yamazaki N; Yamamoto A
Am J Dermatopathol; 2006 Feb; 28(1):56-9. PubMed ID: 16456327
[TBL] [Abstract][Full Text] [Related]
8. Considerations on the performance of immunohistochemistry for mismatch repair gene proteins in cases of sebaceous neoplasms and keratoacanthomas with reference to Muir-Torre syndrome.
Fernandez-Flores A
Am J Dermatopathol; 2012 Jun; 34(4):416-22. PubMed ID: 22123265
[TBL] [Abstract][Full Text] [Related]
9. [Mutation in the MSH2 gene in Muir-Torre syndrome].
Godard V; Coulet F; Bernaudin JF; Housset M; Soubrier F
Ann Dermatol Venereol; 1999; 126(8-9):600-3. PubMed ID: 10530347
[TBL] [Abstract][Full Text] [Related]
10. [Muir-Torre syndrome: rare association with duodenal carcinoma].
Bacha D; Deschamps L; Sauvanet A; Couvelard A
Ann Pathol; 2009 Dec; 29(6):495-8. PubMed ID: 20005439
[TBL] [Abstract][Full Text] [Related]
11. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias.
Kruse R; Rütten A; Schweiger N; Jakob E; Mathiak M; Propping P; Mangold E; Bisceglia M; Ruzicka T
J Invest Dermatol; 2003 May; 120(5):858-64. PubMed ID: 12713593
[TBL] [Abstract][Full Text] [Related]
12. A case of Muir-Torre syndrome with a keratoacanthoma and sebaceous neoplasms: Clinicopathological features and a speculation on the pathogenesis of cutaneous tumor type.
Takayama E; Yoshioka A; Takai T; Goto K
J Dermatol; 2021 May; 48(5):690-694. PubMed ID: 33523490
[TBL] [Abstract][Full Text] [Related]
13. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families.
Ponti G; Ponz de Leon M; Losi L; Di Gregorio C; Benatti P; Pedroni M; Scarselli A; Riegler G; Lembo L; Pellacani G; Seidenari S; Rossi G; Roncucci L
Br J Dermatol; 2005 Jun; 152(6):1335-8. PubMed ID: 15949004
[TBL] [Abstract][Full Text] [Related]
14. [Torre-Muir syndrome. Sebaceous gland neoplasms, keratoacanthomas, multiple internal cancers and heredity].
Worret WI; Burgdorf WH; Fahmy A; Pitha J
Hautarzt; 1981 Oct; 32(10):519-24. PubMed ID: 7298331
[TBL] [Abstract][Full Text] [Related]
15. Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer.
Cesinaro AM; Ubiali A; Sighinolfi P; Trentini GP; Gentili F; Facchetti F
Am J Dermatopathol; 2007 Aug; 29(4):351-8. PubMed ID: 17667167
[TBL] [Abstract][Full Text] [Related]
16. Sebaceous skin lesions as clues to hereditary non-polyposis colorectal cancer.
Lynch HT; Fusaro RM; Lynch PM
J Invest Dermatol; 2006 Oct; 126(10):2158-9. PubMed ID: 16983324
[TBL] [Abstract][Full Text] [Related]
17. [Torre-Muir syndrome. Sebaceous gland tumors indicate colon carcinoma and other internal malignant tumors].
Karsten U; Christophers E; Sterry W
Dtsch Med Wochenschr; 1987 Aug; 112(34):1296-301. PubMed ID: 3622267
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
Abbas O; Mahalingam M
J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
[TBL] [Abstract][Full Text] [Related]
19. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients.
Harwood CA; Swale VJ; Bataille VA; Quinn AG; Ghali L; Patel SV; Dove-Edwin I; Cerio R; McGregor JM
J Invest Dermatol; 2001 Feb; 116(2):246-53. PubMed ID: 11180000
[TBL] [Abstract][Full Text] [Related]
20. "Second hit" in sebaceous tumors from Muir-Torre patients with germline mutations in MSH2: allele loss is not the preferred mode of inactivation.
Kruse R; Rütten A; Hosseiny-Malayeri HR; Bisceglia M; Friedl W; Propping P; Ruzicka T; Mangold E
J Invest Dermatol; 2001 Mar; 116(3):463-5. PubMed ID: 11231323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]